291 related articles for article (PubMed ID: 35538665)
41. A Hot-Segment-Based Approach for the Design of Cross-Amyloid Interaction Surface Mimics as Inhibitors of Amyloid Self-Assembly.
Andreetto E; Malideli E; Yan LM; Kracklauer M; Farbiarz K; Tatarek-Nossol M; Rammes G; Prade E; Neumüller T; Caporale A; Spanopoulou A; Bakou M; Reif B; Kapurniotu A
Angew Chem Int Ed Engl; 2015 Oct; 54(44):13095-100. PubMed ID: 26336938
[TBL] [Abstract][Full Text] [Related]
42. Plasma IAPP-Autoantibody Levels in Alzheimer's Disease Patients Are Affected by
Pocevičiūtė D; Roth B; Schultz N; Nuñez-Diaz C; Janelidze S; The Netherlands Brain Bank ; Olofsson A; Hansson O; Wennström M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835187
[TBL] [Abstract][Full Text] [Related]
43. Role of lysine residue of islet amyloid polypeptide in fibril formation, membrane binding, and inhibitor binding.
Wu MH; Chan AC; Tu LH
Biochimie; 2020 Oct; 177():153-163. PubMed ID: 32860895
[TBL] [Abstract][Full Text] [Related]
44. Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiology.
Jaikaran ET; Clark A
Biochim Biophys Acta; 2001 Nov; 1537(3):179-203. PubMed ID: 11731221
[TBL] [Abstract][Full Text] [Related]
45. Nucleation of β-rich oligomers and β-barrels in the early aggregation of human islet amyloid polypeptide.
Sun Y; Kakinen A; Xing Y; Pilkington EH; Davis TP; Ke PC; Ding F
Biochim Biophys Acta Mol Basis Dis; 2019 Feb; 1865(2):434-444. PubMed ID: 30502402
[TBL] [Abstract][Full Text] [Related]
46. Perspective for Molecular Dynamics Simulation Studies of Amyloid-β Aggregates.
Okumura H
J Phys Chem B; 2023 Dec; 127(51):10931-10940. PubMed ID: 38109338
[TBL] [Abstract][Full Text] [Related]
47. Lysophosphatidylcholine modulates the aggregation of human islet amyloid polypeptide.
Xing Y; Pilkington EH; Wang M; Nowell CJ; Kakinen A; Sun Y; Wang B; Davis TP; Ding F; Ke PC
Phys Chem Chem Phys; 2017 Nov; 19(45):30627-30635. PubMed ID: 29115353
[TBL] [Abstract][Full Text] [Related]
48. Design of a mimic of nonamyloidogenic and bioactive human islet amyloid polypeptide (IAPP) as nanomolar affinity inhibitor of IAPP cytotoxic fibrillogenesis.
Yan LM; Tatarek-Nossol M; Velkova A; Kazantzis A; Kapurniotu A
Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2046-51. PubMed ID: 16467158
[TBL] [Abstract][Full Text] [Related]
49. Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides.
Ren B; Liu Y; Zhang Y; Cai Y; Gong X; Chang Y; Xu L; Zheng J
ACS Chem Neurosci; 2018 May; 9(5):1215-1224. PubMed ID: 29432676
[TBL] [Abstract][Full Text] [Related]
50. On the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP Peptides.
Tomasello MF; Sinopoli A; Pappalardo G
J Diabetes Res; 2015; 2015():918573. PubMed ID: 26582441
[TBL] [Abstract][Full Text] [Related]
51. Characterisation of the Structure and Oligomerisation of Islet Amyloid Polypeptides (IAPP): A Review of Molecular Dynamics Simulation Studies.
Moore SJ; Sonar K; Bharadwaj P; Deplazes E; Mancera RL
Molecules; 2018 Aug; 23(9):. PubMed ID: 30149632
[TBL] [Abstract][Full Text] [Related]
52. Identification of a hinge residue controlling islet amyloid polypeptide self-assembly and cytotoxicity.
Godin E; Nguyen PT; Zottig X; Bourgault S
J Biol Chem; 2019 May; 294(21):8452-8463. PubMed ID: 30975901
[TBL] [Abstract][Full Text] [Related]
53. Effects of Protein Corona on IAPP Amyloid Aggregation, Fibril Remodelling, and Cytotoxicity.
Pilkington EH; Xing Y; Wang B; Kakinen A; Wang M; Davis TP; Ding F; Ke PC
Sci Rep; 2017 May; 7(1):2455. PubMed ID: 28550295
[TBL] [Abstract][Full Text] [Related]
54. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro.
Kayed R; Bernhagen J; Greenfield N; Sweimeh K; Brunner H; Voelter W; Kapurniotu A
J Mol Biol; 1999 Apr; 287(4):781-96. PubMed ID: 10191146
[TBL] [Abstract][Full Text] [Related]
55. Islet amyloid polypeptide tagged with green fluorescent protein localises to mitochondria and forms filamentous aggregates in Caenorhabditis elegans.
Akdag M; van Schijndel V; Sinnige T
Biophys Chem; 2024 Apr; 307():107180. PubMed ID: 38241827
[TBL] [Abstract][Full Text] [Related]
56. Promotion or Inhibition of Islet Amyloid Polypeptide Aggregation by Zinc Coordination Depends on Its Relative Concentration.
Nedumpully-Govindan P; Yang Y; Andorfer R; Cao W; Ding F
Biochemistry; 2015 Dec; 54(50):7335-44. PubMed ID: 26603575
[TBL] [Abstract][Full Text] [Related]
57. Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes.
Anguiano M; Nowak RJ; Lansbury PT
Biochemistry; 2002 Sep; 41(38):11338-43. PubMed ID: 12234175
[TBL] [Abstract][Full Text] [Related]
58. High-Speed Atomic Force Microscopy Reveals the Structural Dynamics of the Amyloid-β and Amylin Aggregation Pathways.
Watanabe-Nakayama T; Sahoo BR; Ramamoorthy A; Ono K
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32560229
[TBL] [Abstract][Full Text] [Related]
59. Insights into the consequences of co-polymerisation in the early stages of IAPP and Aβ peptide assembly from mass spectrometry.
Young LM; Mahood RA; Saunders JC; Tu LH; Raleigh DP; Radford SE; Ashcroft AE
Analyst; 2015 Oct; 140(20):6990-9. PubMed ID: 26193839
[TBL] [Abstract][Full Text] [Related]
60. Human pro-islet amyloid polypeptide (ProIAPP(1-48)) forms amyloid fibrils and amyloid spherulites in vitro.
Exley C; House E; Patel T; Wu L; Fraser PE
J Inorg Biochem; 2010 Oct; 104(10):1125-9. PubMed ID: 20579740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]